Early trial tests 'Ultra-Hot' pepper compound to numb severe cancer pain
NCT ID NCT02522611
Summary
This early-stage study is testing whether an experimental injection called resiniferatoxin (RTX) is safe and can reduce severe, untreatable pain caused by cancer that has spread to the bones. Up to 30 adults who have not found relief from standard pain medications will receive a single injection near their spine. Researchers will monitor participants for about 7 months to check safety, pain levels, and quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTRACTABLE PAIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.